[go: up one dir, main page]

SE9803157D0 - A new composition - Google Patents

A new composition

Info

Publication number
SE9803157D0
SE9803157D0 SE9803157A SE9803157A SE9803157D0 SE 9803157 D0 SE9803157 D0 SE 9803157D0 SE 9803157 A SE9803157 A SE 9803157A SE 9803157 A SE9803157 A SE 9803157A SE 9803157 D0 SE9803157 D0 SE 9803157D0
Authority
SE
Sweden
Prior art keywords
composition
component
disorders
new composition
phthalancarbonitrile
Prior art date
Application number
SE9803157A
Other languages
English (en)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9803157A priority Critical patent/SE9803157D0/sv
Publication of SE9803157D0 publication Critical patent/SE9803157D0/sv
Priority to EEP200100156A priority patent/EE200100156A/xx
Priority to EP99951320A priority patent/EP1121119A1/en
Priority to SK327-2001A priority patent/SK3272001A3/sk
Priority to AU63781/99A priority patent/AU6378199A/en
Priority to CN99811007A priority patent/CN1317963A/zh
Priority to CA002342585A priority patent/CA2342585A1/en
Priority to JP2000569803A priority patent/JP2002524509A/ja
Priority to BR9913765-8A priority patent/BR9913765A/pt
Priority to IL14152099A priority patent/IL141520A0/xx
Priority to HU0103569A priority patent/HUP0103569A3/hu
Priority to CZ2001962A priority patent/CZ2001962A3/cs
Priority to PL99346769A priority patent/PL346769A1/xx
Priority to IDW20010580A priority patent/ID28359A/id
Priority to PCT/SE1999/001598 priority patent/WO2000015219A1/en
Priority to KR1020017003338A priority patent/KR20010099648A/ko
Priority to TR2001/00769T priority patent/TR200100769T2/xx
Priority to ARP990104627A priority patent/AR023657A1/es
Priority to IS5877A priority patent/IS5877A/is
Priority to ZA200101951A priority patent/ZA200101951B/xx
Priority to NO20011313A priority patent/NO20011313L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9803157A 1998-09-16 1998-09-16 A new composition SE9803157D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition
TR2001/00769T TR200100769T2 (tr) 1998-09-16 1999-09-13 Yeni bir bileşim
BR9913765-8A BR9913765A (pt) 1998-09-16 1999-09-13 Composição, uso da composição, método para o tratamento de distúrbios mediados por 5-ht, método de melhoria do inìcio da ação terapêutica, formulação farmacêutica, processo para a preparação da composição, e, kit
HU0103569A HUP0103569A3 (en) 1998-09-16 1999-09-13 New medicament and process for its preparation
SK327-2001A SK3272001A3 (en) 1998-09-16 1999-09-13 A new composition
AU63781/99A AU6378199A (en) 1998-09-16 1999-09-13 A new composition
CN99811007A CN1317963A (zh) 1998-09-16 1999-09-13 新型组合物
CA002342585A CA2342585A1 (en) 1998-09-16 1999-09-13 A new composition
JP2000569803A JP2002524509A (ja) 1998-09-16 1999-09-13 新規組成物
EEP200100156A EE200100156A (et) 1998-09-16 1999-09-13 Uus koostis
IL14152099A IL141520A0 (en) 1998-09-16 1999-09-13 A new composition of (r) -3-n,n-dicyclobutylamino- 8-fluoro-3, 4-dihydro-2h-1-benzopyran-5-carboxamide hydrogen (2r, 3r) - tartrate and 1-c3- (dimethylamino) propyl! -1 (p-fluorophenyl) -5- phthalancarbonitrile
EP99951320A EP1121119A1 (en) 1998-09-16 1999-09-13 A new composition
CZ2001962A CZ2001962A3 (cs) 1998-09-16 1999-09-13 Nový prostředek
PL99346769A PL346769A1 (en) 1998-09-16 1999-09-13 A new composition
IDW20010580A ID28359A (id) 1998-09-16 1999-09-13 Komposisi
PCT/SE1999/001598 WO2000015219A1 (en) 1998-09-16 1999-09-13 A new composition
KR1020017003338A KR20010099648A (ko) 1998-09-16 1999-09-13 신규 조성물
ARP990104627A AR023657A1 (es) 1998-09-16 1999-09-15 Composicion, usos de la misma, formulacion farmaceutica, proceso para la preparacion de la composicion y kit
IS5877A IS5877A (is) 1998-09-16 2001-03-05 Ný efnablanda
ZA200101951A ZA200101951B (en) 1998-09-16 2001-03-08 A new composition.
NO20011313A NO20011313L (no) 1998-09-16 2001-03-15 Ny sammensetning

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
SE9803157D0 true SE9803157D0 (sv) 1998-09-16

Family

ID=20412628

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition

Country Status (21)

Country Link
EP (1) EP1121119A1 (sv)
JP (1) JP2002524509A (sv)
KR (1) KR20010099648A (sv)
CN (1) CN1317963A (sv)
AR (1) AR023657A1 (sv)
AU (1) AU6378199A (sv)
BR (1) BR9913765A (sv)
CA (1) CA2342585A1 (sv)
CZ (1) CZ2001962A3 (sv)
EE (1) EE200100156A (sv)
HU (1) HUP0103569A3 (sv)
ID (1) ID28359A (sv)
IL (1) IL141520A0 (sv)
IS (1) IS5877A (sv)
NO (1) NO20011313L (sv)
PL (1) PL346769A1 (sv)
SE (1) SE9803157D0 (sv)
SK (1) SK3272001A3 (sv)
TR (1) TR200100769T2 (sv)
WO (1) WO2000015219A1 (sv)
ZA (1) ZA200101951B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
DE60122015T2 (de) * 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US20110196032A1 (en) 2005-05-20 2011-08-11 Ashish Gogia Pharmaceutical Dosage Form of an Antidepressant
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
PL346769A1 (en) 2002-02-25
WO2000015219A1 (en) 2000-03-23
CZ2001962A3 (cs) 2001-08-15
NO20011313L (no) 2001-05-16
IL141520A0 (en) 2002-03-10
HUP0103569A3 (en) 2002-03-28
CN1317963A (zh) 2001-10-17
NO20011313D0 (no) 2001-03-15
BR9913765A (pt) 2001-06-05
ID28359A (id) 2001-05-17
IS5877A (is) 2001-03-05
JP2002524509A (ja) 2002-08-06
CA2342585A1 (en) 2000-03-23
SK3272001A3 (en) 2001-09-11
AU6378199A (en) 2000-04-03
TR200100769T2 (tr) 2001-11-21
AR023657A1 (es) 2002-09-04
ZA200101951B (en) 2002-06-10
HUP0103569A2 (hu) 2002-02-28
EP1121119A1 (en) 2001-08-08
KR20010099648A (ko) 2001-11-09
EE200100156A (et) 2002-08-15

Similar Documents

Publication Publication Date Title
SE9501567D0 (sv) A new combination
DE602006021444D1 (de) Therapie zur behandlung der überaktiven blase
EP2343073A3 (en) Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
BG108207A (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
RU97119427A (ru) Сочетание ингибитора усвоения 5-нт с селективным 5-нтia антагонистом
AR015448A1 (es) COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN
SE0102055D0 (sv) New Compounds
BR0308133A (pt) Forma polimórfica cristalina de cloridrato de irinotecan
BR9810773A (pt) Uso de um ingrediente anestésico local de ação prolongada, composição farmacêutica, uso de um anestésico local, e, kit
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
SE9803157D0 (sv) A new composition
WO2004096118A3 (en) Composition for improving cognition and memory
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
HUP0401934A2 (hu) Enantiomerekben dúsított demetil- és didemetil- citalopram metabolitok alkalmazása depresszió és más központi idegrendszeri rendellenességek esetében
SE9804126D0 (sv) New pharmaceutical composition
MXPA02011554A (es) Combinacion de secretagogos de hormona del crecimiento y antidepresivos.
SE9702066D0 (sv) A new salt
SE9803156D0 (sv) A new composition
SE9803158D0 (sv) A new composition
UA89753C2 (ru) Применение модафинила и антидепрессанта при лечении депрессии и для сокращения времени до начала действия антидепрессанта
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
SE9803155D0 (sv) A new composition
NO20050279D0 (no) Ny fremgangsmate
MY136683A (en) Kappa opoid agonist for the treatment of irritable bladder